Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Centessa Pharmaceuticals (CNTA) Revenue (2022 - 2025)

Historic Revenue for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Q1 2025 value amounting to $15.0 million.

  • Centessa Pharmaceuticals' Revenue changed N/A to $15.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 68365.76%. This contributed to the annual value of $6.9 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Revenue of $15.0 million as of Q1 2025.
  • Centessa Pharmaceuticals' 5-year Revenue high stood at $15.0 million for Q1 2025, and its period low was -$2.6 million during Q4 2023.
  • In the last 3 years, Centessa Pharmaceuticals' Revenue had a median value of -$2.2 million in 2022 and averaged -$242666.7.
  • Data for Centessa Pharmaceuticals' Revenue shows a peak YoY increase of 1665.91% (in 2023) and a maximum YoY decrease of 5633.33% (in 2023) over the last 5 years.
  • Centessa Pharmaceuticals' Revenue (Quarter) stood at -$2.2 million in 2022, then fell by 16.66% to -$2.6 million in 2023, then surged by 683.66% to $15.0 million in 2025.
  • Its Revenue stands at $15.0 million for Q1 2025, versus -$2.6 million for Q4 2023 and -$2.5 million for Q3 2023.